Wells Fargo & Company Reiterates “Overweight” Rating for Omega Healthcare Investors (NYSE:OHI)

Omega Healthcare Investors (NYSE:OHI)‘s stock had its “overweight” rating restated by investment analysts at Wells Fargo & Company in a report issued on Tuesday, Benzinga reports. They presently have a $43.00 price target on the real estate investment trust’s stock, up from their previous price target of $40.00. Wells Fargo & Company‘s price objective indicates a potential upside of 7.39% from the company’s previous close.

Other research analysts have also recently issued research reports about the stock. Truist Financial increased their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a report on Wednesday, September 4th. Scotiabank increased their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research note on Monday, August 26th. Finally, Mizuho cut shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their price target for the company from $34.00 to $35.00 in a research note on Thursday, July 25th. Eight research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $35.78.

Omega Healthcare Investors Trading Down 0.9 %

NYSE OHI opened at $40.04 on Tuesday. The company has a market capitalization of $9.89 billion, a PE ratio of 36.07, a P/E/G ratio of 1.32 and a beta of 1.00. The stock has a 50-day simple moving average of $38.95 and a 200 day simple moving average of $34.51. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors has a 12 month low of $27.53 and a 12 month high of $41.53.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm had revenue of $252.70 million for the quarter, compared to the consensus estimate of $205.92 million. During the same period in the prior year, the business earned $0.74 earnings per share. The company’s revenue for the quarter was up 17.5% compared to the same quarter last year. Research analysts forecast that Omega Healthcare Investors will post 2.69 EPS for the current year.

Insider Buying and Selling

In related news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Institutional Trading of Omega Healthcare Investors

A number of hedge funds and other institutional investors have recently bought and sold shares of OHI. Versant Capital Management Inc purchased a new position in shares of Omega Healthcare Investors in the 2nd quarter worth about $26,000. WFA Asset Management Corp purchased a new stake in Omega Healthcare Investors during the first quarter valued at about $39,000. Covestor Ltd increased its position in shares of Omega Healthcare Investors by 47.6% during the first quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock valued at $42,000 after buying an additional 431 shares during the period. Highlander Capital Management LLC increased its position in shares of Omega Healthcare Investors by 52.0% during the first quarter. Highlander Capital Management LLC now owns 1,900 shares of the real estate investment trust’s stock valued at $60,000 after buying an additional 650 shares during the period. Finally, GAMMA Investing LLC increased its position in shares of Omega Healthcare Investors by 93.4% during the second quarter. GAMMA Investing LLC now owns 2,446 shares of the real estate investment trust’s stock valued at $84,000 after buying an additional 1,181 shares during the period. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.